AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.

Back to search results

Modified Huanglian-Jie-Du-Tang for treating neurodegenerative diseases

Summary

This invention is in the field of pharmaceuticals, health supplements, health supplements, and chemical industries. In particular, this invention relates to Huanglian-Jie-Du-Tang (HLJDT), which is a famous traditional Chinese herbal formula that has been widely used clinically to treat cerebral ischemia.

Technology Benefits

Removing a previously unknown ill effect of HLJDT towards the treatment of neurodegenerative diseases

Technology Application

A significantly more potent treatment for neurodegenerative diseases

Detailed Technology Description

This invention relates a modified formula of HLJDT (HLJDT-M) that compensates the Aβ increasing effects of an ethanolic extracts of HLJDT, and its components Radix scutellariae on the regulatory processing of amyloid-β protein precursor (APP),

Application Date

2013.06.13

Application No.

US 61/834,437

Others

Filed

ID No.

A61/LM/Hljd/US0P

Country/Region

Hong Kong

For more information, please click Here